Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_000548.5(TSC2):c.2608G>C(p.Ala870Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.978
PP5
Variant 16-2075861-G-C is Pathogenic according to our data. Variant chr16-2075861-G-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 947280.Status of the report is criteria_provided_single_submitter, 1 stars.
Review Status: criteria provided, single submitter
Collection Method: clinical testing
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has been observed to be de novo in an individual affected with tuberous sclerosis complex (Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change replaces alanine with proline at codon 870 of the TSC2 protein (p.Ala870Pro). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and proline. -
Gain of phosphorylation at Y865 (P = 0.1047);Gain of phosphorylation at Y865 (P = 0.1047);Gain of phosphorylation at Y865 (P = 0.1047);.;Gain of phosphorylation at Y865 (P = 0.1047);Gain of phosphorylation at Y865 (P = 0.1047);Gain of phosphorylation at Y865 (P = 0.1047);Gain of phosphorylation at Y865 (P = 0.1047);.;Gain of phosphorylation at Y865 (P = 0.1047);Gain of phosphorylation at Y865 (P = 0.1047);Gain of phosphorylation at Y865 (P = 0.1047);Gain of phosphorylation at Y865 (P = 0.1047);Gain of phosphorylation at Y865 (P = 0.1047);.;